Preferential inactivation of paediatric solid tumour cells by sequential exposure to Merocyanine 540-mediated photodynamic therapy and Edelfosine: Implications for the ex vivo purging of autologous haematopoietic stem cell grafts

Journal of Photochemistry and Photobiology B: Biology

Volumn 69, Issue 2, 2003, Pages 87-95

  Anderson, Gregory S ^a   Tsujino, Ichiro ^a   Miyagi, Kiyoko ^a   Sampson, Reynée ^a   Sieber, Fritz ^a  

^a MEDICAL COLLEGE OF WISCONSIN   (United States)

Author keywords

Edelfosine; Merocyanine 540; Neuroblastoma; Osteosarcoma; Photodynamic therapy; Purging; Rhabdomyosarcoma; Wilm's tumour

Indexed keywords

ALKYLATING AGENT; CD34 ANTIGEN; DYE; EDELFOSINE; MEROCYANINE; PHOSPHOLIPID DERIVATIVE;

ANIMAL CELL; AUTOLOGOUS BONE MARROW TRANSPLANTATION; BONE MARROW CELL; BONE MARROW PURGING; CANCER CELL CULTURE; CELL ACTIVITY; CELL ASSAY; CELL COUNT; CELL PROTECTION; CELL SURVIVAL; CHILDHOOD CANCER; COLONY FORMING UNIT GM; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG EFFICACY; DRUG EXPOSURE; DRUG SAFETY; DRUG SCREENING; DRUG STRUCTURE; GRANULOCYTE; HEMATOPOIETIC STEM CELL; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; INCUBATION TIME; MACROPHAGE; MOUSE; NEPHROBLASTOMA; NEUROBLASTOMA CELL; NONHUMAN; OSTEOSARCOMA CELL; PHOTODYNAMIC THERAPY; PRIORITY JOURNAL; REVIEW; RHABDOMYOSARCOMA; SOLID TUMOR; STEM CELL; TUMOR CELL;

MURINAE;

EID: 0037295931     PISSN: 10111344     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1011-1344(02)00411-6     Document Type: Review

References (49)

1. I. Yaniv, E. Bouffet, C. Irle, S. Negrier, P. Biron, M. Favrot, I. Philip, M. Brunat-Mentigny, T. Philip, Autologous bone marrow transplantation in pediatric solid tumors, Pediatr. Hematol. Oncol. 7 (1990) 35-46.
2. V.M. Santana, M.J. Schell, R. Williams, L.C. Bowman, E.I. Thompson, M.K. Brenner, J. Mirro Jr., Escalating sequential high-dose carboplatin and etoposide with autologous marrow support in children with relapsed solid tumors, Bone Marrow Transplant. 10 (1992) 457-462.
3. K.K. Matthay, Impact of myeloablative therapy with bone marrow transplantation in advanced neuroblastoma, Bone Marrow Transplant. 18 (1996) S21-S24.
4. European Group for Blood and Marrow Transplant Registry Solid Tumour Working Party, T. Philip, R. Ladenstein, C. Lasset, O. Hartmann, J.M. Zucker, R. Pinkerton, A.D. Pearson, T. Klingebiel, A. Garaventa, B. Kremens, J.L. Bernard, G. Rosti, F. Chauvin, 1070 myeloablative megatherapy procedures followed by stem cell rescue for neuroblastoma: 17 years of European experience and conclusions, Eur. J. Cancer 33 (1997) 2130-2135.
5. F. Boulad, N.A. Kernan, M.P. LaQuaglia, G. Heller, K.L. Lindsley, N.S. Rosenfield, S.J. Abramson, W.L. Gerald, T.N. Small, A.P. Gillio, S.C. Gulati, R.J. O'Reilly, F. Ghavimi, High-dose induction chemoradiotherapy followed by autologous bone marrow transplantation as consolidation therapy in rhabdomyosarcoma, extra-osseous Ewing's sarcoma, and undifferentiated sarcoma, J. Clin. Oncol. 16 (1998) 1697-1706.
6. Children's Cancer Group, K.K. Matthay, J.G. Villablanca, R.C. Seeger, D.O. Stram, R.E. Harris, N.K. Ramsay, P. Swift, H. Shimada, C.T. Black, G.M. Brodeur, R.B. Gerbing, C.P. Reynolds, Treatment of high-risk neuroblastoma with intensive chemotherapy, radiotherapy, autologous bone marrow transplantation, and 13-cis-retinoic acid, New Engl. J. Med. 341 (1999) 1165-1173.
7. W. Leung, A.R. Chen, R.C. Klann, T.J. Moss, J.M. Davis, S.J. Noga, K.J. Cohen, A.D. Friedman, D. Small, C.L. Schwartz, M.J. Borowitz, M.D. Wharam, C.N. Paidas, C.A. Long, S. Karandish, J.D. McMannis, M.B. Kastan, C.I. Civin, Frequent detection of tumor cells in hematopoietic grafts in neuroblastoma and Ewing's sarcoma, Bone Marrow Transplant. 22 (1998) 971-979.
8. R.C. Seeger, C.P. Reynolds, R. Gallego, D.O. Stram, R.B. Gerbing, K.K. Matthay, Quantitative tumor cell content of bone marrow and blood as a predictor of outcome in stage IV neuroblastoma: a Children's Cancer Group Study, J. Clin. Oncol. 18 (2000) 4067-4076.
9. M.K. Brenner, D.R. Rill, R.C. Moen, R.A. Krance, J. Mirro Jr., W.F. Anderson, J.N. Ihle, Gene-marking to trace origin of relapse after autologous bone-marrow transplantation, Lancet 341 (1993) 85-86.
10. W. Krüger, F. Tögel, N. Kröger, S. Rossing, F. Gieseking, K. Gutensohn, C. Lindner, F. Jänicke, A.R. Zander, Tumor detection in G-CSF mobilised stem cell harvests of patients with breast cancer, Med. Oncol. 16 (1999) 17-22.
11. S.K. Kraeft, R. Sutherland, L. Gravelin, G.H. Hu, L.H. Ferland, P. Richardson, A. Elias, L.B. Chen, Detection and analysis of cancer cells in blood and bone marrow using a rare event imaging system, Clin. Cancer Res. 6 (2000) 434-442.
12. N.C. Gorin, P. Aegerter, B. Auvart, G. Meloni, A.H. Goldstone, A. Burnett, A. Carella, M. Korbling, P. Herve, D. Marianinchi, R. Löwenberg, L.F. Verdonck, M. de Planque, J. Hermans, W. Helbig, A. Porcellini, V. Rizzoli, E.P. Alesandrino, I.M. Franklin, J. Reiffers, P. Colleselli, J.M. Goldman, Autologous bone marrow transplantation for acute myelocytic leukemia in first remission. A European survey of the role of marrow purging, Blood 75 (1990) 1606-1614.
13. C.B. Miller, P.A. Rowlings, M.-J. Zhang, R.J. Jones, S. Piantadosi, A. Keating, J.O. Armitage, S. Calderwood, R.E. Harris, J.P. Klein, H.M. Lazarus, C.A. Linker, K.A. Sobocinski, D. Weisdorf, M.M. Horowitz, The effect of graft purging with 4-hydroperoxycyclophosphamide in autologous bone marrow transplantation for acute myelogenous leukemia, Exp. Hematol. 29 (2001) 1336-1346.
14. F. Sieber, Merocyanine 540, Photochem. Photobiol. 46 (1987) 1035-1042, Yearly review.
15. R.C. Meagher, F. Sieber, J.L. Spivak, Susceptibility to Merocyanine 540-mediated photosensitization: a differentiation marker on murine hematopoietic progenitor cells, J. Cell. Physiol. 116 (1983) 118-124.
16. F. Sieber, J.L. Spivak, A.M. Sutcliffe, Selective killing of leukemic cells by merocyanine 540-mediated photosensitization, Proc. Natl. Acad. Sci. U.S.A. 81 (1984) 7584-7587.
17. J. Atzpodien, S.C. Gulati, B.D. Clarkson, Comparison of the cytotoxic effects of merocyanine-540 on leukemic cells and normal human bone marrow, Cancer Res. 46 (1986) 4892-4895.
18. F. Sieber, R.K. Stuart, S.D. Rowley, S.J. Sharkis, L.L. Sensenbrenner, Dye-mediated photolysis of normal and neoplastic hematopoietic cells, Leuk. Res. 11 (1987) 43-49.
19. A. Porcellini, N. Talevi, M.T. Marchetti-Rossi, M. Palazzi, A. Manna, G. Sparaventi, C. Delfini, M. Valentini, Limiting dilution analysis for the determination of leukemic cell frequencies after bone marrow decontamination with mafosfamide or merocyanine 540, Blood 70 (1987) 1543-1549.
20. M. Mumcuoglu, L. Weiss, J. Spivak, S. Slavin, Differential killing of murine B-cell leukemia (BCL1) by photosensitization with merocyanine 540: implications for autologous bone marrow transplantation, Bone Marrow Transplant. 4 (1989) 143-146.
21. F. Sieber, Photosensitizing agents for marrow purging in autologous bone marrow transplantation, in: N.C. Gorin, L. Douay (Eds.), Experimental Hematology Today-1989, Springer-Verlag, New York, 1990, pp. pp. 10-15.
22. T. Itoh, H.A. Messner, N. Jamal, M. Tweeddale, F. Sieber, Merocyanine 540-sensitized photoinactivation of high-grade non-Hodgkin's lymphoma cells: potential application in autologous bone marrow transplantation, Bone Marrow Transplant. 12 (1993) 191-196.
23. Y. Kubo, F. Sieber, Photochemical purging of autologous bone marrow grafts: assessment of damage to stem cells and the microenvironment in long-term marrow cultures, Bone Marrow Transplant. 20 (1997) 27-31.
24. F. Sieber, Extracorporeal purging of bone marrow grafts by dye-sensitized photoirradiation, in: A.P. Gee (Ed.), Bone Marrow Processing and Purging: a Practical Guide, CRC Press, Boca Raton, 1991, pp. 263-280.
25. F. Sieber, M. Sieber-Blum, Dye-mediated photosensitization of murine neuroblastoma cells, Cancer Res. 46 (1986) 2072-2076.
26. F. Sieber, S. Rao, S.D. Rowley, M. Sieber-Blum, Dye-mediated photolysis of human neuroblastoma cells: implications for autologous bone marrow transplantation, Blood 68 (1986) 32-36.
27. G. Bruchelt, G. Grygar, J. Treuner, H. Esterbauer, D. Niethammer, Cytotoxic effects of 6-hydroxydopamine, merocyanine-540 and related compounds on human neuroblastoma and hematopoietic stem cells, Free Radic. Res. Commun. 7 (1989) 205-212.
28. 3 synergistically enhances the Merocyanine 540-mediated photoinactivation of leukemia cells: implications for the extracorporeal purging of autologous hematopoietic stem cells, Bone Marrow Transplant. 19 (1997) 113-119.
29. N.N. Iscove, F. Sieber, K.H. Winterhalter, Erythroid colony formation in cultures of mouse and human bone marrow: analysis of the requirement for erythropoietin by gel filtration and affinity chromatography on agarose-concanavalin-A, J. Cell. Physiol. 83 (1974) 309-320.
30. E. Lydaki, H. Dimitriou, T. Papazoglou, W.Q. Liu, M. Kalmanti, Merocyanine 540 mediated photolysis of normal bone marrow, committed hemopoietic progenitors and neoplastic cells. Implications for bone marrow purging, Leuk. Res. 21 (1997) 641-650.
31. A. Kohler, A. Müller, F. Zintl, Investigation of the usefulness of the photodynamic reaction for the purging of bone marrow from metastatic neuroblastoma cells, J. Photochem. Photobiol. B: Biology 19 (1993) 227-229.
32. L. Glasser, L.B. Somberg, W.R. Vogler, Purging murine leukemic marrow with alkyl-lysophospholipids, Blood 64 (1984) 1288-1291.
33. S. Okamoto, A.C. Olsen, W.E. Berdel, W.R. Vogler, Purging of acute myeloid leukemic cells by ether lipids and hyperthermia, Blood 72 (1988) 1777-1783.
34. W.R. Vogler, W.E. Berdel, A.C. Olson, E.F. Winton, L.T. Heffner, D.S. Gordon, Autologous bone marrow transplantation in acute leukemia with marrow purged with alkyl-lysophospholipid, Blood 80 (1992) 1423-1429.
35. H.F. Dietzfelbinger, A. Lang, D. Oberberg, J.W. Rastetter, W.E. Berdel, Differential cytotoxicity of an ether lipid on lymphoma and bone marrow cells and its role in purging malignant lymphoid cells from remission bone marrow contaminated with tumor cells, Exp. Hematol. 20 (1992) 178-183.
36. H.F. Dietzfelbinger, D. Kuhn, M. Zafferani, A.R. Hanauske, J.W. Rastetter, W.E. Berdel, Removal of breast cancer cells from bone marrow by in vitro purging with ether lipids and cryopreservation, Cancer Res. 53 (1993) 3747-3751.
37. W.R. Vogler, Bone marrow purging in acute leukemia with alkyl-lysophospholipids: a new family of anticancer drugs, Leuk. Lymphoma 13 (1994) 53-60.
38. W.R. Vogler, W.E. Berdel, R.B. Geller, J.A. Brochstein, R.A. Beveridge, W.S. Dalton, K.B. Miller, H.M. Lazarus, A phase II trial of autologous bone marrow transplantation (ABMT) in acute leukemia with edelfosine purged bone marrow, Adv. Exp. Med. Biol. 416 (1996) 389-396.
39. W.U. Knauf, M.P. Koenigsmann, M. Notter, B. Hoppe, B. Reufi, D. Oberberg, E. Thiel, W.E. Berdel, Peripheral blood progenitor mobilization with Dexa-Beam/G-CSF, ether lipid purging, and autologous transplantation after high-dose CBV treatment: a safe and effective regimen in patients with poor risk malignant lymphomas, Leuk. Lymphoma 23 (1996) 305-311.
40. M.P. Koenigsmann, M. Notter, W.U. Knauf, C.A. Papadimitriou, D. Oberberg, B. Reufi, C. Mucke, E. Thiel, W.E. Berdel, Chemopurging of peripheral blood-derived progenitor cells by alkyl-lysophospholipid and its effect on haematopoietic rescue after high-dose therapy, Bone Marrow Transplant. 18 (1996) 549-557.
41. K.F. Mangan, personal communication, 2001.
42. M.J. O'Brien, F. Sieber, Mutagenicity of merocyanine 540-mediated photosensitization, Exp. Hematol. 17 (1989) 166-170.
43. J.E. Valinsky, T.G. Easton, E. Reich, Merocyanine 540 as a fluorescent probe of membranes: selective staining of leukemic and immature hemopoietic cells, Cell 13 (1978) 487-499.
44. D.K. Gaffney, F. Sieber, The role of serum and serum components in the merocyanine 540-sensitized photoinactivation of K562 leukemia cells, Biochim. Biophys. Acta 1117 (1992) 321-325.
45. E.E. Kelley, E.J. Modest, C.P. Burns, Unidirectional membrane uptake of the ether lipid antineoplastic agent edelfosine by L1210 cells, Biochem. Pharmacol. 45 (1993) 2435-2439.
46. 3, Leuk. Res. 19 (1995) 417-425.
47. I. Tsujino, F. Sieber, Genetic variability in the response of normal murine hematopoietic progenitor cells to extracorporeal photochemotherapy, Photochem. Photobiol. 72 (2000) 810-814.
48. S.D. Rowley, M. Zuehlsdorf, H.G. Braine, O.M. Colvin, J. Davis, R.C. Jones, R. Saral, L.L. Sensenbrenner, A. Yeager, G.W. Santos, CFU-GM content of bone marrow grafts correlates with time to hematologic reconstitution following autologous bone marrow transplantation with 4-hydroperoxycyclophosphamide-purged bone marrow, Blood 70 (1987) 272-275.
49. S.D. Rowley, S. Piantadosi, C.D. Marcellus, R.J. Jones, N.E. Davidson, J.M. Davis, J. Kennedy, J.M. Wiley, J.R. Wingard, A.M. Yeager, G.W. Santos, Analysis of factors predicting speed of hematologic recovery after transplantation with 4-hydroperoxycyclophosphamide-purged autologous bone marrow grafts, Bone Marrow Transplant. 7 (1991) 183-191.